Select a Region North America

Maximizing Sales Impact in a Hybrid World

In an evolving pharmaceutical landscape, traditional sales methods are giving way to a new hybrid approach. “Maximizing Sales Impact in a Hybrid World” delves into this transformative shift, exploring how data-driven strategies blend personal and non-personal engagement to optimize customer interactions.

Discover how adaptable content, real-time analytics, and integrated teams are revolutionizing sales, leading to unprecedented revenue advantages. Join us on a journey through innovative methodologies and compelling case studies, as we navigate the future of pharmaceutical sales in Europe and beyond.

Complete the form below to download the full paper.

Author
headshot of Kerem Can Alp
Kerem Can Alp
Product Manager, Commercial

Kerem has over a decade of experience in the pharmaceutical industry, having worked in various capacities within European and US-based organizations. Throughout his career, he has held key roles in business development and strategy,…

Headshot of Adam Hardy, Senior Vice President, Commercial Operations, EVERSANA
Adam Hardy
Senior Vice President, Commercial Operations

Adam Hardy is a leader in the pharmaceutical industry, having worked in the industry for over 15 years in both European and US-based organizations. This experience includes working in all phases of pharmaceutical R&D,…

heasdhot of Airel Salmang
Ariel Salmang
Managing Director, EVERSANA INTOUCH International

Ariel has led impactful digital strategies and implementation across multiple industries, from media and FMCG to telecommunications and healthcare, where he has spent the past 10+ years focusing on the digital evolution of pharma…

Dan Feldman
General Manager, Deployment Solutions, UK, Europe & APAC

With over three decades of senior management expertise, Dan boasts a diverse background in Marketing, Sales, and Business Development across pharmaceuticals, over-the-counter products, medical devices, and both Commercial and Clinical outsourcing services. His career…